Las Vegas
-
15 Nov 2005:
IBM, in occasione della conferenza dedicata a utenti e sviluppatori delle soluzioni di Information Management, annuncia che il proprio software di information integration è stato utilizzato come tecnologia base per un progetto primo nel suo genere e finalizzato alla ricerca di nuove cure per malattie croniche tra le quali epilessia, diabete e alcune tipologie di tumori.
Nell'ambito di un progetto di ricerca avanzata, infatti, Melbourne Health e Bio21 Australia stanno lavorando con IBM alla verifica dei primi modelli informatici di medicina molecolare (Molecular Medicine Informatics Model - MMIM), un sofisticato strumento di analisi dei dati che consente a medici e ricercatori di identificare ed estrarre dati clinici e biotecnici da database multipli appartenenti a diverse istituzioni, combinando i dati più disparati in repository virtuali accanto ai dati di ricerca pubblici e genetici. Melbourne Health ha implementato una soluzione IBM composta da software, hardware e servizi con l'obiettivo di abilitare i propri medici e ricercatori a utilizzare le informazioni come servizio on demand.
Il progetto collega le banche dati di ricerca clinica e dei tessuti biologici di sei istituti sanitari di Melbourne e mira ad analizzare le informazioni di tipo genetiche su epilessia, diabete e tumore al colon e al retto. Obiettivo del progetto è migliorare la ricerca sulle informazioni sanitarie dei pazienti, utilizzando le potenzialità offerte dal mondo IT e della bioinformatica per trattare e rielaborare i dati raccolti al fine di identificare ed implementare cure migliori e più efficaci.
IBM Information Integration Live! è la Conferenza annuale internazionale che è attualmente in corso a Las Vegas dal 13 al 15 novembre 2005.
I temi dell'edizione 2005 sono il progetto "Serrano-Hawk", le nuove funzionalità di IBM Information Integration Solutions e le tecnologie e le architetture emergenti che interessano il mondo dell'information integration.
IBM teams with Melbourne Health to fight chronic disease
IBM Information Integration Live, LAS VEGAS, November 15, 2005—–IBM today announced that its information integration software is serving as the foundation for a first of its kind research project to help uncover new treatments for chronic diseases including cancer, epilepsy and diabetes.
As part of the advanced research project, Melbourne Health and Bio21 Australia are working with IBM to begin testing a Molecular Medicine Informatics Model (MMIM), an advanced data analysis tool which enables doctors and researchers to find and extract biotechnical and clinical data
from multiple databases across multiple institutions, and combine disparate data in a virtual repository alongside publicly available research and genetic profiling data. Melbourne Health has implemented a cross-IBM solution of software, servers and services to help doctors and researchers
leverage healthcare information as a service.
The project links clinical research data, tissue bank and genetic information on epilepsy, diabetes and colorectal cancer from six Melbourne health institutions. The goal of the project is to support clinical patient-related research, using enhanced IT and bioinformatics to process data collected over a long time.
“Important advances in the healthcare industry are increasingly challenged by a proliferation of incompatible document formats and proprietary technology, making it difficult to find, retrieve and share data such as standardized medical records,” said Pete Fiore, vice president, IBM information integration solutions. “IBM’s information integration software is helping free up data from different systems, applications and silos and
making it useful to doctors and researchers, potentially speeding the introduction and delivery of new services in the battle against chronic disease.”
According to Professor Michael Georgeff of Monash University who sits on the Melbourne Health Project Committee, "Finding the databases is not hard. People know where they are, but finding the same patient in each database, making sure they are truly the same patient -- that's quite a sophisticated task, we're probably leading the world because we got on to this first."
The MMIM project is helping Melbourne Health break through the information bottleneck, unlocking valuable information and helping make sense of that data and delivering it for use in the fight against chronic disease. MMIM improves research possibilities by opening the door on larger sample
populations, since data can be collected in a more sophisticated and integrated way and more powerfully analyzed.
“As we deploy Bio21:MMIM more widely, we expect to generate new research that will substantially improve our care by treating patients with the
medicines that are best suited to their genetic profile,” said Peter Gibbs, medical oncologist at The Royal Melbourne Hospital and research Fellow at
the Ludwig Institute for Cancer Research.
MMIM also provides an ability to access important research data in minutes - instead of months – enabling clinical specialists to generate correlations that were previously impossible to discover. These breakthroughs are helping the organization increase their understanding of the causes of disease and the therapies used to treat them.
Melbourne Health’s IBM solution includes IBM Business Consulting Services industry expertise, IBM WebSphere Information Integrator Advanced Edition Unlimited V8.2, WebSphere Application Server Express Edition V5, DB2 Universal Database Enterprise Server Edition V8.2, DB2 Query Management Facility for WebSphere V8.1 and DB2 Query Patroller V8 software, and IBM eServer xSeries 255 servers.
Contatti
Sara Bonini
IBM Media Relations
+39 02 5962.3402
sara_bonini@it.ibm.com
| Argomenti | XML feed |
|---|---|
| Sanità Nessuna descrizione specifica attualmente |
|
| Software Information Management (DB2), Workplace, Portal e Software per la Collaborazione (Lotus), Tivoli, Rational, WebSphere, open standard, open source |